Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Cancer Repository for Cancer Research

NCT02012699 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02012699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Cancer Repository for Cancer Research
Lead sponsor
University of Nebraska
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2013
Completion date
December 31, 2099
Enrollment
Not reported
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, bile duct cancer, bladder cancer, breast cancer, central nervous system cancer, central nervous system tumor, colon cancer, duodenal cancer, endometrial cancer, esophageal cancer, familial adenomatous polyposis, gallbladder cancer, gastric cancer, gastrointestinal stromal tumors, healthy control, hypopharyngeal cancer, kidney cancer, laryngeal cancer, leukemia, lip cancer, liver cancer, lung cancer, lynch syndrome, melanoma, mesothelioma, multiple myeloma, nasal cavity cancer, nasopharyngeal cancer, neuroendocrine tumors, oral cavity cancer, oropharyngeal cancer, ovarian cancer, pancreatic cancer, paranasal sinus cancer, penile cancer, peritoneal surface malignancies, plasma cell dyscrasia, prostate cancer, rectal cancer, salivary gland cancer, sarcoma, skin cancer, small intestine cancer, testicular cancer, thymus cancer, thyroid cancer, unknown primary tumor, ureter cancer, urethral cancer, vaginal cancer